Literature DB >> 6297535

Cervical and serum IgA and serum IgG antibodies to Chlamydia trachomatis and herpes simplex virus in threatened abortion: a prospective study.

M Grönroos, E Honkonen, P Terho, R Punnonen.   

Abstract

The aetiological role of Chlamydia trachomatis (CT) and herpes simplex virus (HSV) was investigated in 189 patients with threatened abortion. Assessment of infection was based on isolation, and on determination of serum immunoglobulin (Ig)G and IgA antibodies as well as cervical IgA antibody levels with new sensitive radioimmunoassay (RIA) techniques. One third of the women were delivered of a healthy infant and two thirds aborted, but the two groups were otherwise clinically similar. By isolation, only 2.7% of the patients were CT-positive, but increased cervical IgA antibody level to CT was detected in 41.3%. The mean level of these local antibodies was similar in both study groups, but the mean levels of serum IgA and IgG antibodies were somewhat higher in the patients who aborted although the difference was not significant. None of the cervical specimens was positive for HSV by isolation but the cervical IgA antibody level to HSV was raised in 47.1% of the patients. Both cervical and serum IgA antibody levels to HSV were significantly raised among the patients who aborted, but there were no differences between the patients with spontaneous abortion and those with a blighted ovum. There was no clear association between CT and abortion, but an association between HSV and abortion is possible. The incidence of raised levels of both CT and HSV IgA antibodies in the cervix was surprisingly high in both groups and the significance of this finding remains to be investigated.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6297535     DOI: 10.1111/j.1471-0528.1983.tb08903.x

Source DB:  PubMed          Journal:  Br J Obstet Gynaecol        ISSN: 0306-5456


  6 in total

Review 1.  Risks associated with viral infections during pregnancy.

Authors:  Karen Racicot; Gil Mor
Journal:  J Clin Invest       Date:  2017-05-01       Impact factor: 14.808

2.  Cervicovaginal neutralizing antibodies to herpes simplex virus (HSV) in women seropositive for HSV Types 1 and 2.

Authors:  Francois-Xavier Mbopi-Kéou; Laurent Bélec; Julie Dalessio; Jérôme Legoff; Gérard Grésenguet; Philippe Mayaud; David W G Brown; Rhoda Ashley Morrow
Journal:  Clin Diagn Lab Immunol       Date:  2003-05

3.  A study of the incidence of urogenital Chlamydia trachomatis in patients attending specialized departments of Rome, Milan and Turin, Italy.

Authors:  M Del Piano; E M Magliano; M A Latino; R Nicosia; R Sessa; P Clerici; R Colombo; C Gordini; A Serio
Journal:  Eur J Epidemiol       Date:  1992-07       Impact factor: 8.082

4.  Diagnostic efficacy of chlamydial antibodies in cervical secretions from pregnant women and adolescent girls.

Authors:  H Thejls; V A Rahm; J Gnarpe; H Gnarpe
Journal:  Genitourin Med       Date:  1995-12

5.  Role of Chlamydia trachomatis in miscarriage.

Authors:  David Baud; Genevieve Goy; Katia Jaton; Maria-Chiara Osterheld; Serafin Blumer; Nicole Borel; Yvan Vial; Patrick Hohlfeld; Andreas Pospischil; Gilbert Greub
Journal:  Emerg Infect Dis       Date:  2011-09       Impact factor: 6.883

6.  Cervical antibodies to herpes simplex virus proteins in pregnancy and puerperium: a pilot study.

Authors:  D H Watts; J M Guise; Z Brown; L Corey; R L Ashley
Journal:  Infect Dis Obstet Gynecol       Date:  1996
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.